Showing results (1-10 of 38) with videos related to
Sort By:
Pageof 4
Current Cancer Drug Targets|August 10, 2012
Angiogenesis in hepatocellular carcinoma: a potential target for chemoprevention and therapyAnupam Bishayee, Altaf S DarveshNutrition and Cancer|March 28, 2013
Chemopreventive and therapeutic potential of tea polyphenols in hepatocellular cancerAltaf S Darvesh, Anupam BishayeeAnti-Cancer Agents in Medicinal Chemistry|April 13, 2010
Selenium in the prevention and treatment of hepatocellular carcinomaAltaf S Darvesh, Anupam BishayeeEuropean Journal of Pharmacology|March 7, 2003
Activation of 5-HT2 receptors induces glycogenolysis in the rat brainAltaf S Darvesh, Gary A GudelskyNeurotoxicology and Teratology|June 19, 2004
The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in ratsAltaf S Darvesh, Gary A GudelskyExpert Review of Neurotherapeutics|December 9, 2014
Pharmacotherapy of Alzheimer's disease: current and future trendsWerner J Geldenhuys, Altaf S DarveshBrain Research|August 16, 2005
Evidence for a role of energy dysregulation in the MDMA-induced depletion of brain 5-HTAltaf S Darvesh, Gary A GudelskyCancer Treatment Reviews|November 14, 2009
Resveratrol in the chemoprevention and treatment of hepatocellular carcinomaAnupam Bishayee, Themos Politis, Altaf S DarveshCurrent Pharmaceutical Biotechnology|April 7, 2011
Curcumin and liver cancer: a reviewAltaf S Darvesh, Bharat B Aggarwal, Anupam BishayeeThe Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
3,4-Methylenedioxymethamphetamine produces glycogenolysis and increases the extracellular concentration of glucose in the rat brainAltaf S Darvesh, Mahalakshmi Shankaran, Gary A GudelskyPageof 4